芪参益气滴丸结合波利维治疗对冠心病炎症因子C反应蛋白和纤维蛋白质的.pdfVIP

芪参益气滴丸结合波利维治疗对冠心病炎症因子C反应蛋白

和纤维蛋白质的影响

李英;惠朋利

【摘要】Objective:TodiscusstheinflammatorycytokinesC‐reactive

protein(CRP),fibrinogen(FIB)effectsofQishenYiqidrippingpills

combinedplavixfortreatingcoronaryheartdisease.Methods:From

february2012tojanuary2015,selected80patientswithcoronaryheart

diseaseaccordedtotheprincipleofrandomdrawwereequallydi‐vided

intocontrolandtreatmentgroupwith40patients,twogroupsweregiven

conventionaltreatmentcardiology,onthisbasis,thecontrolgroupwas

treatedwithplavixtreatment,thetreatmentgroupwastreatedwith

QishenYiqidrippingpillscombinedplavix,alltreatmentfor4

weeks.Results:Allpatientswerecompletedthetreatment,theresponse

ratesinthetreatmentgroupandthecontrolgroupwere95.0%and

87.5%,respectivelythatthetreatmentgroupwassignifi‐cantlyhigher(P

0.05).TheplasmaCRPandFIBexpressionvaluesaftertreatmentwere

significantlydecreased(P0.05),whilethevalueofplasmaCRPandFIBin

thetreatmentgroupaftertreatmentweresignificantlylowerthanthosein

thecontrolgroup(P0.05).Allpatientswerefollowedupforsix

months,theagainmyocardialinfarction,heartfailure,recurrent

angina,coronaryrevascularization,andotheradverseeffectsinthe

treatmentgroupweresignificantlylessthanthoseinthecontrolgroup(P

0.05).Conclusion:TheQishenYiqidrippingpillscombinedplavixfor

trea‐tingcoronaryheartdiseasecanreducetheexpressionofCRPand

FIB,improvetheoveralltreatmenteffect,reducethein‐cidenceoflong‐

termcardiovasculareventsthathasverygoodvalues.%目的：探讨芪参益气

滴丸结合波利维治疗对冠心病炎症因子C反应蛋白（CRP）、纤维蛋白质（FIB）

的影响。方法：选择在我院诊治的冠心病患者80例，根据随机抽签原则分为对照

组与治疗组各40例，两组都给予常规治疗，在此基础上对照组口服波利维治疗，

治疗组口服芪参益气滴丸结合波利维治疗，均治疗4周。结果：所有患者都完成

治疗，治疗组与对照组的有效率分别为95．0％和87．5％，治疗组的治疗有效

率明显高于对照组（P＜0．05）。两组治疗后的血浆CRP与FIB表达值都明显下

降（P＜0．05），同时治疗后治疗组的血浆CRP与